These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 23893384)
1. RACK1 promoted the growth and migration of the cancer cells in the progression of esophageal squamous cell carcinoma. Hu F; Tao Z; Wang M; Li G; Zhang Y; Zhong H; Xiao H; Xie X; Ju M Tumour Biol; 2013 Dec; 34(6):3893-9. PubMed ID: 23893384 [TBL] [Abstract][Full Text] [Related]
2. RACK1 predicts poor prognosis and regulates progression of esophageal squamous cell carcinoma through its epithelial-mesenchymal transition. Wang N; Liu F; Cao F; Jia Y; Wang J; Ma W; Tan B; Wang K; Song Q; Cheng Y Cancer Biol Ther; 2015; 16(4):528-40. PubMed ID: 25719728 [TBL] [Abstract][Full Text] [Related]
3. Overexpression of S-adenosylhomocysteine hydrolase (SAHH) in esophageal squamous cell carcinoma (ESCC) cell lines: effects on apoptosis, migration and adhesion of cells. Li Q; Mao L; Wang R; Zhu L; Xue L Mol Biol Rep; 2014; 41(4):2409-17. PubMed ID: 24430301 [TBL] [Abstract][Full Text] [Related]
4. Receptor for activated C kinase 1 (RACK1): a regulator for migration and invasion in oral squamous cell carcinoma cells. Li J; Guo Y; Feng X; Wang Z; Wang Y; Deng P; Zhang D; Wang R; Xie L; Xu X; Zhou Y; Ji N; Hu J; Zhou M; Liao G; Geng N; Jiang L; Wang Z; Chen Q J Cancer Res Clin Oncol; 2012 Apr; 138(4):563-71. PubMed ID: 22207523 [TBL] [Abstract][Full Text] [Related]
5. RAP1B, a DVL2 binding protein, activates Wnt/beta-catenin signaling in esophageal squamous cell carcinoma. Jia Z; Yang Y; Dengyan Z; Chunyang Z; Donglei L; Kai W; Song Z Gene; 2017 May; 611():15-20. PubMed ID: 28119087 [TBL] [Abstract][Full Text] [Related]
6. [The relationship between RACK1 expression and clinicopathologic information of esophageal squamous cell carcinoma]. Wang ZY; Chen ZL; Feng M; Shi SS; He J; Dai GH Zhonghua Yi Xue Za Zhi; 2011 May; 91(20):1397-400. PubMed ID: 21756811 [TBL] [Abstract][Full Text] [Related]
7. Msi2 plays a carcinogenic role in esophageal squamous cell carcinoma via regulation of the Wnt/β-catenin and Hedgehog signaling pathways. Li Z; Jin H; Mao G; Wu L; Guo Q Exp Cell Res; 2017 Dec; 361(1):170-177. PubMed ID: 29054489 [TBL] [Abstract][Full Text] [Related]
8. Downregulation of MicroRNA-644a Promotes Esophageal Squamous Cell Carcinoma Aggressiveness and Stem Cell-like Phenotype via Dysregulation of PITX2. Zhang JX; Chen ZH; Xu Y; Chen JW; Weng HW; Yun M; Zheng ZS; Chen C; Wu BL; Li EM; Fu JH; Ye S; Xie D Clin Cancer Res; 2017 Jan; 23(1):298-310. PubMed ID: 27407092 [TBL] [Abstract][Full Text] [Related]
9. AJUBA promotes the migration and invasion of esophageal squamous cell carcinoma cells through upregulation of MMP10 and MMP13 expression. Shi X; Chen Z; Hu X; Luo M; Sun Z; Li J; Shi S; Feng X; Zhou C; Li Z; Yang W; Li Y; Wang P; Zhou F; Gao Y; He J Oncotarget; 2016 Jun; 7(24):36407-36418. PubMed ID: 27172796 [TBL] [Abstract][Full Text] [Related]
10. Solute Carrier Family 39 Member 6 Gene Promotes Aggressiveness of Esophageal Carcinoma Cells by Increasing Intracellular Levels of Zinc, Activating Phosphatidylinositol 3-Kinase Signaling, and Up-regulating Genes That Regulate Metastasis. Cheng X; Wei L; Huang X; Zheng J; Shao M; Feng T; Li J; Han Y; Tan W; Tan W; Lin D; Wu C Gastroenterology; 2017 Jun; 152(8):1985-1997.e12. PubMed ID: 28209530 [TBL] [Abstract][Full Text] [Related]
11. RACK1 suppresses gastric tumorigenesis by stabilizing the β-catenin destruction complex. Deng YZ; Yao F; Li JJ; Mao ZF; Hu PT; Long LY; Li G; Ji XD; Shi S; Guan DX; Feng YY; Cui L; Li DS; Liu Y; Du X; Guo MZ; Xu LY; Li EM; Wang HY; Xie D Gastroenterology; 2012 Apr; 142(4):812-823.e15. PubMed ID: 22240482 [TBL] [Abstract][Full Text] [Related]
12. RACK1 promotes radiation resistance in esophageal cancer via regulating AKT pathway and Bcl-2 expression. Liu B; Wang C; Chen P; Wang L; Cheng Y Biochem Biophys Res Commun; 2017 Sep; 491(3):622-628. PubMed ID: 28760343 [TBL] [Abstract][Full Text] [Related]
13. Down-regulation of EphB4 phosphorylation is necessary for esophageal squamous cell carcinoma tumorigenecity. Hu F; Tao Z; Shen Z; Wang X; Hua F Tumour Biol; 2014 Jul; 35(7):7225-32. PubMed ID: 24771266 [TBL] [Abstract][Full Text] [Related]
14. miR-1 suppresses the growth of esophageal squamous cell carcinoma in vivo and in vitro through the downregulation of MET, cyclin D1 and CDK4 expression. Jiang S; Zhao C; Yang X; Li X; Pan Q; Huang H; Wen X; Shan H; Li Q; Du Y; Zhao Y Int J Mol Med; 2016 Jul; 38(1):113-22. PubMed ID: 27247259 [TBL] [Abstract][Full Text] [Related]
15. RACK1 promotes breast carcinoma proliferation and invasion/metastasis in vitro and in vivo. Cao XX; Xu JD; Xu JW; Liu XL; Cheng YY; Wang WJ; Li QQ; Chen Q; Xu ZD; Liu XP Breast Cancer Res Treat; 2010 Sep; 123(2):375-86. PubMed ID: 19946739 [TBL] [Abstract][Full Text] [Related]
16. MiR-99a suppresses proliferation, migration and invasion of esophageal squamous cell carcinoma cells through inhibiting the IGF1R signaling pathway. Mei LL; Qiu YT; Huang MB; Wang WJ; Bai J; Shi ZZ Cancer Biomark; 2017 Dec; 20(4):527-537. PubMed ID: 28800315 [TBL] [Abstract][Full Text] [Related]
17. Downregulation of miR-138 sustains NF-κB activation and promotes lipid raft formation in esophageal squamous cell carcinoma. Gong H; Song L; Lin C; Liu A; Lin X; Wu J; Li M; Li J Clin Cancer Res; 2013 Mar; 19(5):1083-93. PubMed ID: 23319823 [TBL] [Abstract][Full Text] [Related]
18. Downregulation of VGLL4 in the progression of esophageal squamous cell carcinoma. Jiang W; Yao F; He J; Lv B; Fang W; Zhu W; He G; Chen J; He J Tumour Biol; 2015 Feb; 36(2):1289-97. PubMed ID: 25352025 [TBL] [Abstract][Full Text] [Related]
19. RAD18 promotes the migration and invasion of esophageal squamous cell cancer via the JNK-MMPs pathway. Zou S; Yang J; Guo J; Su Y; He C; Wu J; Yu L; Ding WQ; Zhou J Cancer Lett; 2018 Mar; 417():65-74. PubMed ID: 29306013 [TBL] [Abstract][Full Text] [Related]
20. Targeting oncogenic PLCE1 by miR-145 impairs tumor proliferation and metastasis of esophageal squamous cell carcinoma. Cui XB; Li S; Li TT; Peng H; Jin TT; Zhang SM; Liu CX; Yang L; Shen YY; Li SG; Li N; Li Y; Hu JM; Jiang JF; Suo J; Qi Y; Liang WH; Wang LH; Dang HW; Li L; Cao WW; Wei Y; Laibo-Yin ; Wu CY; Yuan XL; Zhou H; Zheng Y; Chen YZ; Li F Oncotarget; 2016 Jan; 7(2):1777-95. PubMed ID: 26657507 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]